{
    "Trade/Device Name(s)": [
        "VITEK 2 AST-Gram Positive Daptomycin",
        "VITEK 2 AST-GP Daptomycin",
        "VITEK 2 AST-GP Daptomycin (\u22640.12 - \u22658 \u03bcg/mL)"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K230864",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091126"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LTT",
        "LTW"
    ],
    "Summary Letter Date": "March 22, 2023",
    "Summary Letter Received Date": "March 29, 2023",
    "Submission Date": "June 12, 2020",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Daptomycin"
    ],
    "Specimen Type(s)": [
        "Saline suspension of organism"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK 2",
        "VITEK 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated quantitative antimicrobial susceptibility test",
        "Microdilution minimum inhibitory concentration (MIC) technique"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Microdilution"
    ],
    "Submission Type(s)": [
        "Susceptibility Card"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST-GP Daptomycin card for automated antimicrobial susceptibility testing of Gram positive organisms on VITEK 2 systems",
    "Indications for Use Summary": "Designed for antimicrobial susceptibility testing of Gram positive microorganisms, including Enterococcus faecalis and Staphylococcus aureus, using VITEK 2 and VITEK 2 Compact Systems as a laboratory aid in determining in vitro susceptibility to antimicrobial agents",
    "fda_folder": "Microbiology"
}